Xiaoyan Yin

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Merck Serono S.A. (Switzerland)

Université Félix Houphouët-Boigny

University of Basel

Swiss Tropical and Public Health Institute

Xiaoyan Yin is an author at Merck KGaA, Darmstadt (Germany) specializing in pediatric infectious diseases, transcriptional regulation networks, and morphogenesis.

ORCID

Publications per year

2015–2023

Publications

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Eliézer K. N’Goran, Maurice R. Odiere, Ronald Assandé Aka et al. · The Lancet Infectious Diseases · 2023 · 33 citations

Pharmacy, Child Health, Pediatrics +14

AP2XII-1 is a negative regulator of merogony and presexual commitment in <i>Toxoplasma gondii</i>

Fuqiang Fan, Lilan Xue, Xiaoyan Yin et al. · mBio · 2023 · 28 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Multiple imputation and analysis for high‐dimensional incomplete proteomics data

Xiaoyan Yin, Daniel Levy, Christine Willinger et al. · Statistics in Medicine · 2015 · 27 citations · Full text

Public Health, Biochemistry, Biostatistics +16

Comparison of POC-CCA with Kato-Katz in Diagnosing Schistosoma mansoni Infection in a Pediatric L-Praziquantel Clinical Trial

Xiaoyan Yin, Eliézer K. N’Goran, Mamadou Ouattara et al. · Frontiers in Tropical Diseases · 2021 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

1–4 of 4